Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
I2o Therapeutics is a biotech company that develops safe and effective oral formulations of therapies.
Tisento Therapeutics is a MA-based developer of novel medicines to treat diseases with significant unmet medical needs.
Inozyme is a biopharmaceutical company developing therapeutics for rare diseases, with a focus on bone health.
Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes.
QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.
Avilar Therapeutics is a biopharmaceutical company focusing on extracellular protein degradation.
Provention Bio is a clinical stage biopharmaceutical dedicated to sourcing, developing, and commercializing novel therapeutics.
SwipeRx is a developer of a medical technology platform designed to connect pharmaceutical manufacturers, pharmacies, and patients.
Escient Pharmaceuticals is a privately-held biotechnology company focusing on the advancement of G Protein-Coupled Receptor targeted drugs.
Livmed's is a software platform that provides home medicine delivery services for fellow citizens and healthcare players.
Dice Therapeutics is a clinical-stage biopharmaceutical company that makes medicines for chronic autoimmune and inflammatory diseases.
Thermalin offers insulins and delivery systems that transform the economic, treatment, and disease management paradigms for diabetes.
Empatica is an affective computing company focused on human data analytics.
Portal Instruments is an early stage company that offers medical device.
Gyroscope Therapeutics is a clinical-stage gene therapy company focused on developing therapies and treating diseases of the eye.
SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.
Altesa is a clinical-stage biopharmaceutical company dedicated to accelerating the development of new treatments
GluBio Therapeutics engages in molecular glue-targeted protein degradation drug discovery.
QuantX Biosciences is a biotechnology company that specializes in computational drug discovery and small-molecule therapeutic products.
Mirador Therapeutics develops precision medicines for immune-mediated diseases.
Alveus Therapeutics is a clinical-stage biotech company developing therapies for obesity and metabolic diseases.
InduPro deevlops proximity-based protein therapeutics that modulate cell-surface protein interactions to treat disease.
Enable Injections develops and manufactures wearable drug delivery systems centered on the enFuse platform.
Rology is an AI-assisted On-demand Teleradiology Platform.
Sanofi has invested in 127 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Sanofi's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Pharmaceutical. The firm invests across 23 different industry categories.
Among tracked funding rounds, Dice Therapeutics received $345.0M in a Post-IPO Equity round. Sanofi's total known invested capital is $6.2B.
Sanofi's average investment size is $103.0M across its portfolio of 127 companies.
Recent Sanofi portfolio additions include i2o Therapeutics, Tisento Therapeutics, Inozyme, Veralox Therapeutics, QurAlis. These companies were founded in 2020 or later.